Mimedx (MDXG) Change in Inventory (2011 - 2026)
Mimedx's (MDXG) quarterly Change in Inventory came in at $889000.0 in Q1 2026, up 238.02% year-on-year from $263000.0 in Q1 2025, and up 176.51% quarter-over-quarter from -$1.2 million in Q4 2025.
Mimedx (MDXG) Change in Inventory (2011 - 2026) Analysis & Trends
Mimedx has disclosed Change in Inventory across 16 years of filings, most recently posting $889000.0 for Q1 2026.
- Change in Inventory for Q1 2026 came in at $889000.0, up 238.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 772.59% YoY), and the FY2025 annual result was $1.5 million, down 34.96% from the prior year.
- Change in Inventory came in at $889000.0 for Q1 2026 at Mimedx, up from -$1.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $2.9 million in Q1 2024 to a low of -$1.2 million in Q4 2025.
- The 5-year median for Change in Inventory is $820000.0 (2025), against an average of $847705.9.
- Across the five-year window, Change in Inventory tumbled 238.7% in 2022 and soared 918.4% in 2023, its largest moves.
- Mimedx's Change in Inventory stood at -$792000.0 in 2022, then jumped by 346.59% to $2.0 million in 2023, then sank by 122.53% to -$440000.0 in 2024, then plunged by 164.09% to -$1.2 million in 2025, then surged by 176.51% to $889000.0 in 2026.
- The last three Change in Inventory figures came in at $889000.0 (Q1 2026), -$1.2 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 889,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 889,000.00 |
| Mar 31, 2026 | 889,000.00 |
| Dec 31, 2025 | -1.16 Mn |
| Dec 31, 2025 | -1.16 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 820,000.00 |
| Jun 30, 2025 | 820,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | -440,000.00 |
| Dec 31, 2024 | -440,000.00 |
| Sep 30, 2024 | -807,000.00 |
| Sep 30, 2024 | -807,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Mar 31, 2024 | 2.94 Mn |
| Mar 31, 2024 | 2.94 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2023 | 1.95 Mn |